These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 12049568)

  • 1. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.
    Wax MK; Myers LL; Gabalski EC; Husain S; Gona JM; Nabi H
    Arch Otolaryngol Head Neck Surg; 2002 Jun; 128(6):703-7. PubMed ID: 12049568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chest radiography or chest CT plus head and neck CT versus
    Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
    Mani N; George MM; Nash L; Anwar B; Homer JJ
    Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
    Gourin CG; Watts TL; Williams HT; Patel VS; Bilodeau PA; Coleman TA
    Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography in the evaluation of the N0 neck.
    Myers LL; Wax MK; Nabi H; Simpson GT; Lamonica D
    Laryngoscope; 1998 Feb; 108(2):232-6. PubMed ID: 9473074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of chest CT scanning in the management of patients presenting with head and neck cancer.
    Houghton DJ; Hughes ML; Garvey C; Beasley NJ; Hamilton JW; Gerlinger I; Jones AS
    Head Neck; 1998 Oct; 20(7):614-8. PubMed ID: 9744461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
    Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J
    Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
    Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
    Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography in the evaluation of stage III and IV head and neck cancer.
    Teknos TN; Rosenthal EL; Lee D; Taylor R; Marn CS
    Head Neck; 2001 Dec; 23(12):1056-60. PubMed ID: 11774391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
    Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
    Myers LL; Wax MK
    J Otolaryngol; 1998 Dec; 27(6):342-7. PubMed ID: 9857320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer.
    Fogh SE; Kubicek GJ; Champ C; Intenzo C; Axelrod R; Keane WM; Machtay MM
    Am J Clin Oncol; 2012 Aug; 35(4):311-5. PubMed ID: 22772424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET evaluation of head and neck cancer: value of imaging the thorax.
    Keyes JW; Chen MY; Watson NE; Greven KM; McGuirt WF; Williams DW
    Head Neck; 2000 Mar; 22(2):105-10. PubMed ID: 10679897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
    Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
    Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.
    Strobel K; Haerle SK; Stoeckli SJ; Schrank M; Soyka JD; Veit-Haibach P; Hany TF
    Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):919-27. PubMed ID: 19205699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
    Fischbein NJ; AAssar OS; Caputo GR; Kaplan MJ; Singer MI; Price DC; Dillon WP; Hawkins RA
    AJNR Am J Neuroradiol; 1998 Aug; 19(7):1189-96. PubMed ID: 9726451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.
    Gayed I; Vu T; Johnson M; Macapinlac H; Podoloff D
    Mol Imaging Biol; 2003; 5(1):26-31. PubMed ID: 14499159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities: a retrospective review.
    Lee J; Aronchick JM; Alavi A
    Chest; 2001 Dec; 120(6):1791-7. PubMed ID: 11742903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.
    Stokkel MP; ten Broek FW; Hordijk GJ; Koole R; van Rijk PP
    Ann Surg; 2000 Feb; 231(2):229-34. PubMed ID: 10674615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.